TSCAN THERAPEUTICS INC's ticker is and the CUSIP is 89854M101. A total of 29 filers reported holding TSCAN THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $91,041 | +2.4% | 35,563 | 0.0% | 0.11% | +11.8% |
Q2 2023 | $88,908 | +19.0% | 35,563 | 0.0% | 0.10% | +14.6% |
Q1 2023 | $74,682 | +35.5% | 35,563 | 0.0% | 0.09% | +27.1% |
Q4 2022 | $55,123 | -49.9% | 35,563 | 0.0% | 0.07% | -72.2% |
Q3 2022 | $110,000 | -1.8% | 35,563 | 0.0% | 0.25% | -0.8% |
Q2 2022 | $112,000 | +12.0% | 35,563 | 0.0% | 0.25% | +46.0% |
Q1 2022 | $100,000 | -37.5% | 35,563 | 0.0% | 0.17% | -23.3% |
Q4 2021 | $160,000 | -46.1% | 35,563 | 0.0% | 0.23% | -59.0% |
Q3 2021 | $297,000 | – | 35,563 | – | 0.55% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DC Funds, LP | 630,000 | $1,323,000 | 30.82% |
Deer Management Co. LLC | 1,245,505 | $2,615,561 | 0.24% |
Simplify Asset Management Inc. | 546,916 | $1,148,524 | 0.16% |
Alphabet Inc. | 1,077,080 | $2,261,868 | 0.12% |
Newtyn Management, LLC | 236,800 | $497,280 | 0.10% |
DC Investments Management, LLC | 35,563 | $74,682 | 0.09% |
Privium Fund Management (UK) Ltd | 15,825 | $40,987 | 0.03% |
Baker Brothers Advisors | 2,784,792 | $5,848,063 | 0.03% |
Tekla Capital Management LLC | 200,000 | $420,000 | 0.02% |
NewEdge Wealth, LLC | 91,463 | $192,072 | 0.01% |